98%
921
2 minutes
20
Background: Early-phase F-18 FP-CIT PET/CT (PET) has been reported to possibly replace FDG PET/CT (PET) in the differential diagnosis of parkinsonism. We investigated the correlation between PET and PET to explore their potential interchangeability.
Method: Our retrospective study included 187 participants, categorized into Parkinson's disease (PD), atypical parkinsonian disorders (APD), and participants with intact dopamine transporters (DAT). We analyzed the correlation of standardized uptake value ratios (SUVR) from early-phase PET and PET scans across 23 different brain volumes-of-interest using Pearson's correlation analysis. We conducted this analysis for all participants collectively and then separately for each group.
Results: For all participants without grouping, a moderate correlation (with correlation coefficients R ranging from 0.360 in right putamen to 0.530 in left caudate nucleus) was observed between Early-phase PET and PET. PD group showed a weak to moderate correlation (0.226 in left frontal cortex ≤ R ≤ 0.555 in right cerebellum). APD group revealed a moderate correlation with R ranging from 0.488 in right cerebellum to 0.692 in right occipital cortex. Conversely, a lack of correlation in specific areas for DAT group indicated distinctions between the modalities.
Conclusions: Our study showed interchangeability with a moderate correlation between early-phase PET and PET. However, careful consideration is needed for DAT group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.compbiomed.2025.110177 | DOI Listing |
Ann Nucl Med
September 2025
Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Objective: This study aims to systematically evaluate the inter- and intra-observer agreement regarding lesions with uncertain malignancy potential in Ga-68 PSMA PET/CT imaging of prostate cancer patients, utilizing the PSMA-RADS 2.0 classification system, and to emphasize the malignancy evidence associated with these lesions.
Methods: We retrospectively reviewed Ga-68 PSMA PET/CT images of patients diagnosed with prostate cancer via histopathology between December 2016 and November 2023.
Int J Surg
September 2025
Department of Respiratory and Critical Care Medicine, Hubei Province Clinical Research Center for Major Respiratory Diseases, Key Laboratory of Pulmonary Diseases of National Health Commission, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Background: Precise preoperative discrimination of invasive lung adenocarcinoma (IA) from preinvasive lesions (adenocarcinoma in situ [AIS]/minimally invasive adenocarcinoma [MIA]) and prediction of high-risk histopathological features are critical for optimizing resection strategies in early-stage lung adenocarcinoma (LUAD).
Methods: In this multicenter study, 813 LUAD patients (tumors ≤3 cm) formed the training cohort. A total of 1,709 radiomic features were extracted from the PET/CT images.
Small
September 2025
School of Photovoltaic and Renewable Energy Engineering, University of New South Wales, Sydney, 2052, Australia.
Plastic waste continues to be a major environmental challenge, worsened by energy-intensive conventional recycling methods that require highly pure feedstocks. In this review, emerging electrochemical upcycling technologies are critically examined, focusing on the electro-oxidation transformation of polyethylene terephthalate (PET) into valuable chemical products. Key reaction pathways and target products are outlined to clarify the selective electrochemical reforming of PET.
View Article and Find Full Text PDFSmall
September 2025
State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
Polyethylene terephthalate (PET) glycolysis presents an effective solution to address plastic pollution while promoting the utilization of renewable resources. It is highly important to gain in-depth insights into the identification of the well-defined active sites and the structure-activity relationships in PET glycolysis. Herein, PW@UiO-67 with different exposed crystal facets, i.
View Article and Find Full Text PDFAnn Clin Transl Neurol
September 2025
Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Background: Plasma p-tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p-tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MCI) and subjective cognitive decline (SCD).
Methods: We consecutively enrolled 163 patients (50 SCD, 70 MCI, and 43 AD-demented (AD-d)), who underwent plasma p-tau181 analysis with the Simoa assay.